Jennifer Uram

Research Associate

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jennifer Uram is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Cancer Vaccines Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Granulocyte-Macrophage Colony-Stimulating Factor Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Feasibility Studies Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2017

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Le, D., Uram, J., Smith, K., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., Wong, F., Azad, N., Rucki, A. A., Laheru, D., Donehower, R. C., Zaheer, A., Fisher, G. A., Crocenzi, T. S., Lee, J. J., Greten, T. F. & 26 others, Duffy, A. G., Ciombor, K. K., Eyring, A. D., Lam, B. H., Joe, A., Kang, S. P., Holdhoff, M., Danilova, L. V., Cope, L., Meyer, C., Zhou, S., Goldberg, R. M., Armstrong, D. K., Bever, K., Nickles Fader, A. N., Taube, J. M., Housseau, F., Spetzler, D., Xiao, N., Pardoll, A. M., Papadopoulos, N., Kinzler, K. W., Eshleman, J., Vogelstein, B., Anders, R. A. & Diaz, L. A., Jul 28 2017, In : Science. 357, 6349, p. 409-413 5 p.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Disease-Free Survival
Turcot syndrome
Colorectal Neoplasms

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

De Remigis, A., De Gruijl, T. D., Uram, J., Tzou, S. C., Iwama, S., Talor, M. V., Armstrong, T. D., Santegoets, S. J. A. M., Slovin, S. F., Zheng, L., Laheru, D., Jaffee, E., Gerritsen, W. R., Van Den Eertwegh, A. J. M., Le, D. & Caturegli, P. P., Jan 1 2015, In : International Journal of Cancer. 136, 1, p. 127-137 11 p.

Research output: Contribution to journalArticle


PD-1 blockade in tumors with mismatch-repair deficiency

Le, D., Uram, J., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N., Laheru, D., Biedrzycki, B., Donehower, R. C., Zaheer, A., Fisher, G. A., Crocenzi, T. S., Lee, J. J., Duffy, S. M., Goldberg, R. M., De La Chapelle, A., Koshiji, M. & 15 others, Bhaijee, F., Huebner, T., Hruban, R. H., Wood, L. D., Cuka, N., Pardoll, A. M., Papadopoulos, N., Kinzler, K. W., Zhou, S., Cornish, T. C., Taube, J. M., Anders, R. A., Eshleman, J., Vogelstein, B. & Diaz, L. A., Jun 25 2015, In : New England Journal of Medicine. 372, 26, p. 2509-2520 12 p.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Colorectal Neoplasms
Disease-Free Survival
Survival Rate

Safety and survival with GVAX pancreas prime and Listeria monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer

Le, D., Wang-Gillam, A., Picozzi, V., Greten, T. F., Crocenzi, T., Springett, G., Morse, M., Zeh, H., Cohen, D., Fine, R. L., Onners, B., Uram, J., Laheru, D., Lutz, E. R., Solt, S., Murphy, A. L., Skoble, J., Lemmens, E., Grous, J., Dubensky, T. & 2 others, Brockstedt, D. G. & Jaffee, E., Apr 20 2015, In : Journal of Clinical Oncology. 33, 12, p. 1325-1333 9 p.

Research output: Contribution to journalArticle

Listeria monocytogenes
Pancreatic Neoplasms

A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer

Chen, G., Gupta, R., Petrik, S., Laiko, M., Leatherman, J. M., Asquith, J. M., Daphtary, M. M., Garrett-Mayer, E., Davidson, N. E., Hirt, K., Berg, M., Uram, J., Dauses, T., Fetting, J. H., Duus, E. M., Atay-Rosenthal, S., Ye, X., Wolff, A. C., Stearns, V., Jaffee, E. & 1 others, Emens, L. A., Oct 1 2014, In : Cancer immunology research. 2, 10, p. 949-961 13 p.

Research output: Contribution to journalArticle

Cancer Vaccines
Feasibility Studies
Granulocyte-Macrophage Colony-Stimulating Factor